CClinicalTrials.gg
CompletedNCT07297082Updated Apr 13, 2026

Regional Anesthesia in Ambulatory Endovenous Ablation Surgery

An interventional study of Femoral nerve block and Spinal anesthesia in Discharge Time, Spinal Anesthesia and Ambulatory Surgery, sponsored by Ankara Etlik City Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by Ankara Etlik City Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Varicose veins represent irreversible, abnormal dilatations of the venous structures. They manifest as tortuous, swollen vessels visible beneath the skin of the lower extremities, particularly the feet and legs. Symptoms typically worsen with prolonged standing or sitting. In the early stages, conservative management options-such as the use of compression (elastic) stockings and frequent elevation of the legs-may be effective. In more advanced cases involving extensive varicosities, invasive interventions including sclerotherapy or endovascular ablation may be indicated. These procedures can be performed under local, regional, or general anesthesia.

Spinal anesthesia is a neuraxial technique that produces temporary sensory, motor, and sympathetic blockade through the subarachnoid administration of local anesthetics, with or without adjuvant agents. Clinically, it is commonly employed for surgeries involving the lower extremities, lower abdomen, perineal, gluteal, inguinal, and rectal regions, as well as select urologic and obstetric procedures.

A femoral nerve block is a regional anesthesia technique that involves ultrasound-guided injection of local anesthetic around the femoral nerve in the inguinal region. It provides effective analgesia for the anterior thigh, knee joint, and medial aspect of the lower leg. In endovenous laser ablation (EVLA), a femoral block can offer adequate sensory blockade to serve as a sole anesthetic technique.

02

Conditions studied

  • Discharge Time
  • Spinal Anesthesia
  • Ambulatory Surgery
  • Femoral Nerve Block

Keywords

  • Ambulatory surgery
  • Endovenous laser ablation
  • Discharge Time
  • Femoral nerve block
  • Spinal Anesthesia
03

In context

Lead sponsor

Ankara Etlik City Hospital is the lead sponsor of 166 studies on the registry; 75 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged 18-80 years
  • American Society of Anesthesiologists (ASA) score I-II
  • Body Mass Index (BMI) between 18-30 kg/m2

Exclusion criteria

Exclusion Criteria:

  • Patients under 18 and over 80 years of age
  • ASA score III and above
  • BMI below 18 or above 30 kg/m2
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    Femoral Nerve Block

    Procedure: Femoral nerve block

  • Active comparator
    Spinal anesthesia

    Procedure: Spinal anesthesia

Interventions

  • ProcedureFemoral nerve block

    After monitoring, the patient is in the supine position and the femoral area on the side to be treated is sterilized. A femoral nerve block is then performed using 20 cc of 1% lidocaine using an ultrasound-guided blocking needle.

  • ProcedureSpinal anesthesia

    After monitoring, patients will be placed in the lateral decubitus position. Following appropriate field sterilization, patients will receive unilateral spinal anesthesia with 6 mg bupivacaine. Five minutes after spinal anesthesia, patients will be placed in the supine position.

06

What researchers measure

Primary outcomes

  1. Discharge time

    The time (minutes) from the application of spinal anesthesia or femoral nerve block to the patients' discharge will be recorded as the discharge period

    Time frame: On the operation day

Secondary outcomes

  1. Motor block disappearing time

    Time (minutes) to disappearance of complete motor block in the lower extremity

    Time frame: On the operation day

  2. Sensorial block disappearing time

    Time (minutes) to disappearance of sensorial block in the lower extremity

    Time frame: On the operation day

07

Study locations

1 site
  • İbrahim Topcu
    Etimesgut, Ankara 06170, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07297082
Lead sponsor
Ankara Etlik City Hospital
Responsible party
İbrahim Topcu (Principal Investigator, Ankara Etlik City Hospital) — Principal investigator
First posted
Dec 22, 2025
Start date
Dec 25, 2025
Primary completion
Apr 2, 2026
Completion
Apr 8, 2026
Last update
Apr 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion